Hematerra Technologies, LLC

Hematerra Technologies, LLC, a for-profit limited liability company based in Baltimore, Maryland, develops and maintains blood-bank software systems and medical device tracking solutions for federal healthcare agencies as a prime contractor, operating exclusively in the full-and-open (non-set-aside) space. The company holds two named subsidiaries — Champion Medical Technologies, Inc., and Stacs DNA Inc. — and specializes in healthcare IT and inventory management for transfusion medicine operations.

Hematerra's federal footprint is highly concentrated with a single customer: the National Institutes of Health Clinical Center accounts for 8 awards totaling $788 thousand in combined potential value, or 86% of the vendor's total federal revenue. The portfolio comprises six software maintenance and support purchase orders for Hematerra's HemaComply suite (HemaComply-Lab, HemaComply-Equipment Manager, HemaControl1, and HemaConnect Donor System), all supporting the NIH Clinical Center's Department of Transfusion Medicine and blood bank operations under FDA licensing and AABB accreditation. Representative work includes $132.5 thousand for preventative maintenance and software support (May 2026 – April 2027), $128.7 thousand for HemaComply software maintenance (May 2025 – April 2026), $124.9 thousand for maintenance of HemaConnect and related systems (May 2024 – April 2025), and $121.3 thousand for HemaConnect and HemaComply support (May 2023 – April 2024). A single award from the NIH Office of Logistics and Acquisition Operations for $132.5 thousand rounds out recent activity. All awards carry firm fixed-price purchase order structures with no set-aside designation.

Activity remains flat at one award per year from 2022 through 2026, with combined potential value of $921 thousand across nine prime awards since 2019. One award worth $132.5 thousand reaches ultimate completion within the next twenty-four months. Hematerra does not hold seats on government-wide vehicles or multiple-award IDIQs; all work flows through direct purchase orders from NIH. The vendor operates exclusively as a prime contractor with zero subcontract activity in the source data, and carries no SBA certifications (8(a), HUBZone, SDVOSB, WOSB, or other set-aside designations) across its federal footprint. The narrow customer base and single-agency concentration present recompete risk centered on NIH's continued renewal of annual maintenance and support services for blood-banking systems.